Literature DB >> 17061528

Shigella flexneri strains produce bacteriocins active against members of the human microbial intestinal flora.

Carlos Padilla1, Olga Lobos, Elizabeth Hubert.   

Abstract

The principal aim of this work was to detect the bacteriocinogenic capacity of S. flexneri strains on members of the human intestinal flora. A total of 49 bacteriocinogenic S. flexneri strains were isolated from individuals of both sexes and different ages. The bacteriocins were detected by means of the drop method using E. coli and B. fragilis as target strains. The serotypes of the S. flexneri were determined. The producer capacity of bacteriocins was analysed in 10 different colonies of the same cellular clone and also the arbitrary units were determined. The highest number of bacteriocinogenic S. flexneri strains were obtained from diarrhoeal individuals from 0-10 years old and the S. flexneri serotype 2a was the most abundant. It was demonstrated that E. coli and B. fragilis isolated from the normal intestinal flora of healthy individuals were susceptible to the bacteriocinogenic S. flexneri strains. By means of the determination of arbitrary units per ml of the bacteriocin, it was demonstrated that colonies from a single colony isolate of a same clone of bacteriocinogenic S. flexneri produce different quantities of bacteriocin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 17061528

Source DB:  PubMed          Journal:  Rev Latinoam Microbiol        ISSN: 0187-4640


  2 in total

1.  Partial Characterization of Novel Bacteriocin SF1 Produced by Shigella flexneri and Their Lethal Activity on Members of Gut Microbiota.

Authors:  Carlos Padilla; Verónica Carrasco-Sánchez; Andrés Padilla; Olga Lobos
Journal:  Int J Microbiol       Date:  2019-05-06

2.  Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.

Authors:  Samira Soltani; Riadh Hammami; Paul D Cotter; Sylvie Rebuffat; Laila Ben Said; Hélène Gaudreau; François Bédard; Eric Biron; Djamel Drider; Ismail Fliss
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.